A
new research report by Transparency Market Research offers a
comprehensive evaluation of the global Transcriptomics
Market. The
study, titled “Transcriptomics
Market - Global Industry Analysis, Size, Share, Growth, Trends,
Forecast 2016 - 2024”,
is available for sale on the firm’s website.
Global
Transcriptomics Market: Brief Account
Transcriptomics
incorporates the exploration and assortment of transcriptomes and
finds diverse applications, chiefly in molecular genetics. The global
transcriptomics market could see a whole lot of instances of new
product launch. For example, Trio RNA-Seq launched by NuGEN
Technologies, Inc. is particularly suited for low abundance
transcripts applications as it offers an extremely sensitive whole
transcriptomics solution. This innovation embodies three powerful
technologies, viz. single primer isothermal amplification (SPIA),
DimerFree, and AnyDeplete, for performing high sensitivity
ribonucleic acid (RNA) analysis.
View
Report Preview:
In
terms of end use, type of product, and technology, the global
transcriptomics market could be segmented to help participants make a
careful analysis and find authentic growth opportunities.
The
authors of the report have taken into account all the important
aspects of the global transcriptomics market in order to provide a
deep insight for buyers to ensure a lasting advancement in the
business.
Global
Transcriptomics Market: Trends and Opportunities
The
international transcriptomics market is expected to gain impetus from
the increasing amount of investments directed toward research and
development activities in molecular genetics. Newer innovations such
as those pertaining to next-generation sequencing (NGS) and RNA
interference (RNAi) have birthed as a result of the technological
advancements in the international transcriptomics market. With
improved precision and accuracy, these cutting-edge technologies can
be put to use with a view to help researchers analyze the
transcriptional activity of a vast range of diverse organisms. This
will in turn assist to furnish precise outcomes and manage colossal
quantities of transcriptomics data with the help of improved data
analysis practices.
High
cost of service on account of the dearth of trained professionals and
high input cost is projected to discourage end users from opting for
transcriptomics. Howbeit, cheaper and novel technologies that keep
cost in view are anticipated to set the tone for the global
transcriptomics market. The analysts foresee a steady growth over the
forecast years on the part of the global transcriptomics market as
cardiac diseases coupled with pollution-related ailments spread their
presence worldwide. Biotechnology research and drug innovation
actively and extensively employ transcriptomics technologies.
Global
Transcriptomics Market: Geographical Study
Prophesied
to register a significant CAGR for the forecast years, Asia Pacific
could rely on countries such as India, Japan, and China for its
strong growth in the global transcriptomics market. The region is
predicted to fuel the demand in the global transcriptomics market on
the back of a widespread presence of a ballooning count of biotech as
well as pharma firms. This could be underpinned by the tangible
economic growth and government support witnessed therein.
However,
North America is envisioned to be crowned as the maximum shareholder
in the global transcriptomics market. The dominance of this regional
transcriptomics market could be due to the development and existence
of top-tier pharmaceutical and biotechnology companies, especially in
the U.S. The Middle East, Africa, Europe, and Latin America could be
the other vital regions making a statement in the global
transcriptomics market.
Request
to view Sample Report:
Global
Transcriptomics Market: Competitive Scenario
Some
of the top players functioning in the global transcriptomics market
are Becton, GE Healthcare, Roche Diagnostics, Agilent Technologies,
and Thermo Fisher Scientific. With most end users purchasing reagents
in bulk, vendors in the global transcriptomics market could be
benefited with a larger revenue in the transcriptomics consumables
sector. Enzymes, reagents, and assays are frequently procured for the
purpose of performing various tests in the transcriptomics
consumables sector.
No comments:
Post a Comment